Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Long-Term Glycemic Variability and the Risk of Cardiovascular Diseases in Type 2 Diabetic Patients: Effect of Hypothetical Interventions Using Parametric G-Formula in a Population-Based Historical Cohort Study Publisher Pubmed



K Maajani KHADIJE ; E Nasliesfahani ENSIEH ; N Fahimfar NOUSHIN ; A Sheidaei ALI ; Ma Mansournia Mohammad ALI ; K Yazdani KAMRAN
Authors

Source: PLOS ONE Published:2025


Abstract

Background Harmful effects of long-term HbA1c and fasting plasma glucose (FPG) variability on cardiovascular diseases (CVD) have not been causally examined. We employed a parametric g-formula to estimate the causal effect of HbA1C and fasting plasma glucose (FPG) variability on CVD. Methods This retrospective cohort study was conducted on 2078 patients with type 2 diabetes who were free of CVD and aged >18 years at the entrance to the clinic (2017–2022), with at least three HbA1c and FPG measurements. Variability was calculated using standard deviation (SD), and coefficient of variation (CV). We used the parametric g-formula to estimate the 5-year risk, risk ratio, and risk difference of CVD under different deciles of HbA1c-SD/CV, FPG-SD/CV, HbA1C levels (≤5%, 5 to ≤7%, and >7), and joint exposure to different deciles of HbA1c-SD and HbA1c values, adjusted for time-varying confounders that are affected by prior exposure. Results The observed and simulated 5-year risk of CVD under no intervention were 11.6% (95% CI: 10.3, 13.1) and 11.03% (95% CI: 10.2, 12.6) for HbA1C-SD model. The estimated 5-year risk of CVD was increased from the 8.01% (95% CI: 7.5, 10.1%) in the first decile to 15.2% (95% CI: 14.1, 17.7%) in the tenth decile of HbA1c-SD. The results for FPG-SD were similar. Within the stable level of HbA1c (5 to ≤7%) the risk ratio increased from 1.37 (95% CI: 1.19, 1.48) in the first decile to 2.76 (95% CI: 2.06, 3.09) in the tenth decile of HbA1c-SD. Under a joint intervention of HbA1c <5% and the first decile of HbA1c-SD, CVD risk decreased by 6.4% (95%CI: 4.9, 7.3%) compared to the natural course. Conclusions Even within a stable HbA1c level, long-term glycemic variability may be a strong predictor of CVD. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Global Variation in Diabetes Diagnosis and Prevalence Based on Fasting Glucose and Hemoglobin A1c, Nature Medicine (2023)
2. Estimating the Attributable Risk of Vascular Disorders in Different Ranges of Fasting Plasma Glucose and Assessing the Effectiveness of Anti-Diabetes Agents on Risk Reduction; Questioning the Current Diagnostic Criteria, Journal of Diabetes and Metabolic Disorders (2020)
3. Effects of Diabetes Definition on Global Surveillance of Diabetes Prevalence and Diagnosis: A Pooled Analysis of 96 Population-Based Studies With 331 288 Participants, The Lancet Diabetes and Endocrinology (2015)
Experts (# of related papers)
View all Related Experts
Alireza Esteghamati (6)
Samaneh Akbarpour (3)
Other Related Docs
4. The Association Between Index-Year, Average, and Variability of the Triglyceride-Glucose Index With Health Outcomes: More Than a Decade of Follow-Up in Tehran Lipid and Glucose Study, Cardiovascular Diabetology (2024)
5. What Is the Impact of Vitamin D Supplementation on Glycemic Control in People With Type-2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trails, BMC Endocrine Disorders (2023)
6. Estimated Glucose Disposal Rate and Risk of Cardiovascular Events in Type 1 Diabetes: A Systematic Review and Meta-Analysis, Diabetology and Metabolic Syndrome (2025)
7. Fasting Hyperinsulinaemia and 2-H Glycaemia Predict Coronary Heart Disease in Patients With Type 2 Diabetes, Diabetes and Metabolism (2016)
8. 12-Year Trends in Cardiovascular Risk Factors (2002-2005 Through 2011-2014) in Patients With Cardiovascular Diseases: Tehran Lipid and Glucose Study, PLoS ONE (2018)
9. Trends in Anthropometric Indexes, Blood Pressure, Smoking and Lipids Over a Decade in Diabetic and Non-Diabetic Populations: Tehran Lipid and Glucose Study, Iranian Journal of Epidemiology (2015)
10. Association Between Visit-To-Visit Variability of Glycemic Indices and Lipid Profile and the Incidence of Coronary Heart Disease in Adults With Type 2 Diabetes, Journal of Diabetes and Metabolic Disorders (2021)
11. Revising the Fasting Glucose Threshold for Detection of Cardiovascular Risk Factors: Analysing Two Representative Population-Based Studies of More Than 50000 Iranians in 3 Years: The National Survey of Risk Factors for Non-Communicable Diseases of Iran, Annals of Human Biology (2015)
12. Estimated Glucose Disposal Rate: A Potential Determinant for Microvascular and Macrovascular Complications in Type 2 Diabetes, Endocrinology, Diabetes and Metabolism (2025)
13. Impact of Gluten-Free Diet (Gfd) on Some of Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis, Journal of Nutritional Science (2024)
14. Risk and Age of Cardiovascular Event in Women With Metabolic Syndrome: Menopause Age in Focus, Metabolic Syndrome and Related Disorders (2018)
15. Associations of Total Legume, Pulse, and Soy Consumption With Incident Type 2 Diabetes: Federated Meta-Analysis of 27 Studies From Diverse World Regions, Journal of Nutrition (2021)
16. A Systematic Review, Meta-Analysis, Dose-Response, and Meta-Regression of the Effects of Acarbose Intake on Glycemic Markers in Adults, Journal of Diabetes and Metabolic Disorders (2023)
17. Complex Association of Serum Alanine Aminotransferase With the Risk of Future Cardiovascular Disease in Type 2 Diabetes, Atherosclerosis (2016)
18. Ultra-Processed Food Consumption and Adult Diabetes Risk: A Systematic Review and Dose-Response Meta-Analysis, Nutrients (2021)
19. Sex-Specific Clinical Outcomes of Impaired Glucose Status: A Long Follow-Up From the Tehran Lipid and Glucose Study, European Journal of Preventive Cardiology (2019)
20. Association of Major Dietary Patterns With Advanced Glycation End Products and High-Sensitivity C-Reactive Protein in People With Type 1 Diabetes Mellitus, Nutrition Journal (2023)